Liminatus Pharma, Inc. Class A Common Stock (LIMN) Earnings
NASDAQ·Healthcare·Biotechnology
$3.50
-3.58%
Mkt Cap $6.34M
EPS — Estimate vs Actual
Mkt Cap
$6.34M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.91
NASDAQ·Healthcare·Biotechnology
$3.50
-3.58%
Mkt Cap $6.34M
Mkt Cap
$6.34M
P/E
—
Fwd P/E
—
P/S
—
Rev TTM
—
EPS TTM
-$2.91